In vitro intrinsic clearance-based optimization of N3-phenylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonists.
Hartz, Richard A
In vitro intrinsic clearance-based optimization of N3-phenylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonists. [electronic resource] - Journal of medicinal chemistry Jul 2009 - 4161-72 p. digital
Publication Type: Journal Article
1520-4804
10.1021/jm900302q doi
Animals
Humans
Inhibitory Concentration 50
Male
Metabolic Clearance Rate
Pyrazines--chemistry
Rats
Receptors, Corticotropin-Releasing Hormone--antagonists & inhibitors
CRF Receptor, Type 1
In vitro intrinsic clearance-based optimization of N3-phenylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonists. [electronic resource] - Journal of medicinal chemistry Jul 2009 - 4161-72 p. digital
Publication Type: Journal Article
1520-4804
10.1021/jm900302q doi
Animals
Humans
Inhibitory Concentration 50
Male
Metabolic Clearance Rate
Pyrazines--chemistry
Rats
Receptors, Corticotropin-Releasing Hormone--antagonists & inhibitors
CRF Receptor, Type 1